Transition Therapeutics Inc Stock

Stocks

16-08-25	Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	PR
16-06-03	Transition Therapeutics : Receives Notification From NASDAQ	PR
16-05-11	Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	PR
16-05-09	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	PR
16-04-18	Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	PR

1 day

+0.52%

Manager	Title	Age	Since
Antonio F. Cruz CEO	Chief Executive Officer	73	1998-07-05

Director	Title	Age	Since
Antonio F. Cruz CHM	Chairman	73	2010-08-03

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TRANSITION THERAPEUTICS INC	+0.52%	-6.31%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+1.27%	+0.24%	+21.26%	-7.53%	67.6B
UCB	-0.30%	-6.04%	+38.46%	+193.04%	51.32B
SAMSUNG BIOLOGICS CO.,LTD.	+1.10%	+38.30%	+38.30%	+38.30%	42.97B
CSL LIMITED	+0.16%	-2.85%	-50.72%	-52.88%	40.81B
BIOGEN INC.	+2.76%	-1.56%	+54.70%	-29.29%	29.12B
MODERNA, INC.	+1.25%	-7.48%	+116.21%	-43.73%	27.09B
INCYTE CORPORATION	+0.18%	-1.85%	+68.63%	+86.35%	22.99B
INNOVENT BIOLOGICS, INC.	-2.94%	+9.09%	+9.28%	+199.05%	21.55B
BRIDGEBIO PHARMA, INC.	-1.70%	+5.53%	+76.00%	+353.68%	16.2B
Average	+0.23%	+0.41%	+41.35%	+81.89%	35.52B
Weighted average by Cap.	+0.47%	-0.30%	+33.59%	+58.98%

Employees

Sector